78 related articles for article (PubMed ID: 1435720)
1. [Tumor marker (CA19-9, DU-PAN 2, SPAN 1) levels in cystic fluid of benign liver cyst: preliminary report].
Iwase K; Takenaka H; Yagura A; Oshima S; Nishimura Y; Yoshidome K; Tanaka T
Nihon Geka Gakkai Zasshi; 1992 Aug; 93(8):872. PubMed ID: 1435720
[No Abstract] [Full Text] [Related]
2. Determination of tumor marker levels in cystic fluid of benign liver cysts.
Iwase K; Takenaka H; Oshima S; Yagura A; Nishimura Y; Yoshidome K; Tanaka T
Dig Dis Sci; 1992 Nov; 37(11):1648-54. PubMed ID: 1385056
[TBL] [Abstract][Full Text] [Related]
3. Comparative studies of DU-PAN-2, carcinoembryonic antigen, and CA19-9 in the serum and bile of patients with pancreatic and biliary tract diseases: evaluation of the influence of obstructive jaundice.
Ohshio G; Manabe T; Watanabe Y; Endo K; Kudo H; Suzuki T; Tobe T
Am J Gastroenterol; 1990 Oct; 85(10):1370-6. PubMed ID: 2220731
[TBL] [Abstract][Full Text] [Related]
4. Tumor markers in pancreatic cancer--current concepts.
Schmiegel W
Hepatogastroenterology; 1989 Dec; 36(6):446-9. PubMed ID: 2693300
[TBL] [Abstract][Full Text] [Related]
5. Carbohydrate antigen 19-9 is extremely elevated in polycystic liver disease.
Waanders E; van Keimpema L; Brouwer JT; van Oijen MG; Aerts R; Sweep FC; Nevens F; Drenth JP
Liver Int; 2009 Oct; 29(9):1389-95. PubMed ID: 19515221
[TBL] [Abstract][Full Text] [Related]
6. Expression of CA19-9, DU-PAN-2, and SPan-1 antigens on two types of normal salivary mucins.
Ho JJ; Norton K; Chung YS; Kim YS
Oncol Res; 1993; 5(9):347-56. PubMed ID: 7518709
[TBL] [Abstract][Full Text] [Related]
7. Expression of carbohydrate antigens (SSEA-1, sialyl-Lewis X, DU-PAN-2 and CA19-9) and E-selectin in urothelial carcinoma of the renal pelvis, ureter, and urinary bladder.
Kajiwara H; Yasuda M; Kumaki N; Shibayama T; Osamura Y
Tokai J Exp Clin Med; 2005 Sep; 30(3):177-82. PubMed ID: 16285609
[TBL] [Abstract][Full Text] [Related]
8. Serum concentration and immunohistochemical localization of SPan-1 antigen in pancreatic cancer. A comparison with CA19-9 antigen.
Takeda S; Nakao A; Ichihara T; Suzuki Y; Nonami T; Harada A; Koshikawa T; Takagi H
Hepatogastroenterology; 1991 Apr; 38(2):143-8. PubMed ID: 1855772
[TBL] [Abstract][Full Text] [Related]
9. Secretion and expression of epithelial markers supports the biliary origin of solitary nonparasitic cyst of the liver in infancy.
Otani Y; Takayasu H; Ishimaru Y; Okamura K; Yamagishi J; Ikeda H
J Pediatr Surg; 2005 Dec; 40(12):e27-30. PubMed ID: 16338290
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic usefulness and limitation of measuring pancreatic cancer associate antigen, SPan-1, in patients with pancreatic cancer].
Satake K; Chung YS; Umeyama K; Takeuchi T; Kim YS
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1139-46. PubMed ID: 2730018
[TBL] [Abstract][Full Text] [Related]
11. [Significance of CA19-9 in mature cystic teratoma].
Ito K
Nihon Sanka Fujinka Gakkai Zasshi; 1992 May; 44(5):524-8. PubMed ID: 1619311
[TBL] [Abstract][Full Text] [Related]
12. Expression of mucin-like carcinoma-associated antigen in the cyst fluid differentiates mucinous from nonmucinous pancreatic cysts.
Sperti C; Pasquali C; Pedrazzoli S; Guolo P; Liessi G
Am J Gastroenterol; 1997 Apr; 92(4):672-5. PubMed ID: 9128321
[TBL] [Abstract][Full Text] [Related]
13. Elevated carbohydrate antigen (Ca19-9) levels in hepatic and renal cystic fluid.
Caroli-Bosc FX; Harris AG; Hastier P; Hoffman P; Delmont J
Am J Gastroenterol; 1994 Apr; 89(4):640-2. PubMed ID: 8147379
[No Abstract] [Full Text] [Related]
14. Cyst fluid CA 125 levels in ovarian epithelial neoplasms.
Menczer J; Ben-Baruch G; Moran O; Lipitz S
Obstet Gynecol; 1993 Jan; 81(1):25-8. PubMed ID: 8416456
[TBL] [Abstract][Full Text] [Related]
15. Proliferation tissue polypeptide antigen distinguishes malignant mucinous cystadenocarcinomas from benign cystic tumors and pseudocysts.
Yang JM; Southern JF; Warshaw AL; Lewandrowski KB
Am J Surg; 1996 Jan; 171(1):126-9; discussion 129-30. PubMed ID: 8554126
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of CA 72-4 assay as a tumor marker].
Konishi F
Nihon Rinsho; 1990 Feb; 48 Suppl():974-7. PubMed ID: 2355638
[No Abstract] [Full Text] [Related]
17. [Mucoid carcinoma antigen--a new tumor marker].
Bieglmayer C; Szepesi T; Neunteufel W
Gynakol Rundsch; 1988; 28 Suppl 2():203-5. PubMed ID: 3234919
[No Abstract] [Full Text] [Related]
18. Expression of monoclonal antibody-defined tumor markers in four carcinomas.
Wu JT
Ann Clin Lab Sci; 1989; 19(1):17-26. PubMed ID: 2916833
[TBL] [Abstract][Full Text] [Related]
19. [Immunologically defined tumor-associated antigens: the possibilities and limitations of their use in gastroenterology].
Schmiegel W
Immun Infekt; 1988 Dec; 16(6):213-9. PubMed ID: 3061930
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical staining of pancreatic cancer with CA19-9, KM01, unabsorbed CEA, and absorbed CEA. A comparison with normal pancreas and chronic pancreatitis.
Shimizu M; Saitoh Y; Ohyanagi H; Itoh H
Arch Pathol Lab Med; 1990 Feb; 114(2):195-200. PubMed ID: 1689141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
